TrialDiabetes2025

Empagliflozin Enhances Hepatic Glucose Production and Reduces Total-Body Norepinephrine Turnover Rate: A Randomized Trial.

Siham Abdelgani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.